Which has higher valuation and earnings, COO or ALC?

Alcon has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cooper Companies $4.09B 3.21 $374.90M $2.02 33.34 Alcon $10.40B 3.18 $980M $1.66 40.25

Is COO or ALC more profitable?

Alcon has a net margin of 7.70% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.85% beat Alcon's return on equity. Company Net Margins Return on Equity Return on Assets Cooper Companies 5.57% 10.85% 7.28% Alcon 7.70% 7.11% 4.98%

Does the media prefer COO or ALC?

In the previous week, Cooper Companies had 31 more articles in the media than Alcon. MarketBeat recorded 33 mentions for Cooper Companies and 2 mentions for Alcon. Alcon's average media sentiment score of 1.24 beat Cooper Companies' score of 0.28 indicating that Alcon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 9 Very Positive mention(s) 2 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 3 Very Negative mention(s) Neutral Alcon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend DXCM or ALC?

DexCom currently has a consensus target price of $82.63, indicating a potential upside of 13.40%. Alcon has a consensus target price of $85.12, indicating a potential upside of 27.42%. Given Alcon's higher probable upside, analysts plainly believe Alcon is more favorable than DexCom. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 1 Sell rating(s) 3 Hold rating(s) 19 Buy rating(s) 3 Strong Buy rating(s) 2.92 Alcon 1 Sell rating(s) 6 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.63

Which has higher earnings and valuation, DXCM or ALC?

Alcon has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 6.03 $836.30M $2.34 31.14 Alcon $10.40B 3.18 $980M $1.66 40.25

Is DXCM or ALC more profitable?

DexCom has a net margin of 19.31% compared to Alcon's net margin of 7.70%. DexCom's return on equity of 33.33% beat Alcon's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 19.31% 33.33% 13.19% Alcon 7.70% 7.11% 4.98%

Does the media prefer DXCM or ALC?

In the previous week, DexCom had 26 more articles in the media than Alcon. MarketBeat recorded 28 mentions for DexCom and 2 mentions for Alcon. Alcon's average media sentiment score of 1.24 beat DexCom's score of 1.07 indicating that Alcon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 20 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Alcon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ALC or HCA?

HCA Healthcare has higher revenue and earnings than Alcon. HCA Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.40B 3.18 $980M $1.66 40.25 HCA Healthcare $75.60B 1.09 $6.78B $29.08 12.80

Is ALC or HCA more profitable?

HCA Healthcare has a net margin of 8.89% compared to Alcon's net margin of 7.70%. Alcon's return on equity of 7.11% beat HCA Healthcare's return on equity. Company Net Margins Return on Equity Return on Assets Alcon 7.70% 7.11% 4.98% HCA Healthcare 8.89% -295.93% 11.21%

Does the media refer more to ALC or HCA?

In the previous week, HCA Healthcare had 15 more articles in the media than Alcon. MarketBeat recorded 17 mentions for HCA Healthcare and 2 mentions for Alcon. Alcon's average media sentiment score of 1.24 beat HCA Healthcare's score of 0.71 indicating that Alcon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HCA Healthcare 5 Very Positive mention(s) 8 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, THC or ALC?

Tenet Healthcare has higher revenue and earnings than Alcon. Tenet Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tenet Healthcare $21.31B 0.66 $1.41B $19.23 8.43 Alcon $10.40B 3.18 $980M $1.66 40.25

Does the media favor THC or ALC?

In the previous week, Tenet Healthcare had 10 more articles in the media than Alcon. MarketBeat recorded 12 mentions for Tenet Healthcare and 2 mentions for Alcon. Tenet Healthcare's average media sentiment score of 1.31 beat Alcon's score of 1.24 indicating that Tenet Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tenet Healthcare 11 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alcon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, ALC or EHC?

Alcon has higher revenue and earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.40B 3.18 $980M $1.66 40.25 Encompass Health $5.94B 1.74 $566.20M $5.99 17.43

Does the media refer more to ALC or EHC?

In the previous week, Encompass Health had 5 more articles in the media than Alcon. MarketBeat recorded 7 mentions for Encompass Health and 2 mentions for Alcon. Encompass Health's average media sentiment score of 1.34 beat Alcon's score of 1.24 indicating that Encompass Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Encompass Health 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Alcon (ALC) Competitors

$66.81 +0.23 (+0.34%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$66.81 +0.00 (+0.00%)

As of 06/5/2026 05:48 PM Eastern

Compare

ALC vs. COO, DXCM, HCA, THC, and EHC

Should you buy Alcon stock or one of its competitors? MarketBeat compares Alcon with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alcon include Cooper Companies (COO), DexCom (DXCM), HCA Healthcare (HCA), Tenet Healthcare (THC), and Encompass Health (EHC). These companies are all part of the "medical" sector.

How does Alcon compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 1.5% of Alcon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cooper Companies has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Alcon has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

Cooper Companies presently has a consensus price target of $82.64, indicating a potential upside of 22.72%. Alcon has a consensus price target of $85.12, indicating a potential upside of 27.42%. Given Alcon's stronger consensus rating and higher probable upside, analysts clearly believe Alcon is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	2 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.47
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

In the previous week, Cooper Companies had 31 more articles in the media than Alcon. MarketBeat recorded 33 mentions for Cooper Companies and 2 mentions for Alcon. Alcon's average media sentiment score of 1.24 beat Cooper Companies' score of 0.28 indicating that Alcon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	9 Very Positive mention(s)	2 Positive mention(s)	12 Neutral mention(s)	1 Negative mention(s)	3 Very Negative mention(s)	Neutral
Alcon	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alcon has a net margin of 7.70% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.85% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.85%	7.28%
Alcon	7.70%	7.11%	4.98%

Alcon has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.21	$374.90M	$2.02	33.34
Alcon	$10.40B	3.18	$980M	$1.66	40.25

Summary

Alcon beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Alcon compare to DexCom?

DexCom (NASDAQ:DXCM) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

DexCom has a beta of 1.45, suggesting that its stock price is 45% more volatile than the broader market. Comparatively, Alcon has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

In the previous week, DexCom had 26 more articles in the media than Alcon. MarketBeat recorded 28 mentions for DexCom and 2 mentions for Alcon. Alcon's average media sentiment score of 1.24 beat DexCom's score of 1.07 indicating that Alcon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	20 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Alcon	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DexCom currently has a consensus target price of $82.63, indicating a potential upside of 13.40%. Alcon has a consensus target price of $85.12, indicating a potential upside of 27.42%. Given Alcon's higher probable upside, analysts plainly believe Alcon is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

DexCom has a net margin of 19.31% compared to Alcon's net margin of 7.70%. DexCom's return on equity of 33.33% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	19.31%	33.33%	13.19%
Alcon	7.70%	7.11%	4.98%

Alcon has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	6.03	$836.30M	$2.34	31.14
Alcon	$10.40B	3.18	$980M	$1.66	40.25

97.8% of DexCom shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 0.3% of DexCom shares are owned by company insiders. Comparatively, 1.5% of Alcon shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

DexCom beats Alcon on 11 of the 17 factors compared between the two stocks.

How does Alcon compare to HCA Healthcare?

Alcon (NYSE:ALC) and HCA Healthcare (NYSE:HCA) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

Alcon currently has a consensus price target of $85.12, suggesting a potential upside of 27.42%. HCA Healthcare has a consensus price target of $506.14, suggesting a potential upside of 35.95%. Given HCA Healthcare's higher probable upside, analysts clearly believe HCA Healthcare is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63
HCA Healthcare	1 Sell rating(s)	7 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.63

HCA Healthcare has higher revenue and earnings than Alcon. HCA Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.18	$980M	$1.66	40.25
HCA Healthcare	$75.60B	1.09	$6.78B	$29.08	12.80

In the previous week, HCA Healthcare had 15 more articles in the media than Alcon. MarketBeat recorded 17 mentions for HCA Healthcare and 2 mentions for Alcon. Alcon's average media sentiment score of 1.24 beat HCA Healthcare's score of 0.71 indicating that Alcon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HCA Healthcare	5 Very Positive mention(s)	8 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Alcon has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, HCA Healthcare has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market.

53.9% of Alcon shares are owned by institutional investors. Comparatively, 62.7% of HCA Healthcare shares are owned by institutional investors. 1.5% of Alcon shares are owned by company insiders. Comparatively, 1.5% of HCA Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

HCA Healthcare has a net margin of 8.89% compared to Alcon's net margin of 7.70%. Alcon's return on equity of 7.11% beat HCA Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
HCA Healthcare	8.89%	-295.93%	11.21%

Summary

HCA Healthcare beats Alcon on 10 of the 17 factors compared between the two stocks.

How does Alcon compare to Tenet Healthcare?

Tenet Healthcare (NYSE:THC) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

Tenet Healthcare has a net margin of 7.94% compared to Alcon's net margin of 7.70%. Tenet Healthcare's return on equity of 25.55% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenet Healthcare	7.94%	25.55%	5.15%
Alcon	7.70%	7.11%	4.98%

Tenet Healthcare currently has a consensus price target of $244.16, suggesting a potential upside of 50.53%. Alcon has a consensus price target of $85.12, suggesting a potential upside of 27.42%. Given Tenet Healthcare's stronger consensus rating and higher possible upside, equities analysts plainly believe Tenet Healthcare is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenet Healthcare	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.82
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

Tenet Healthcare has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market. Comparatively, Alcon has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

In the previous week, Tenet Healthcare had 10 more articles in the media than Alcon. MarketBeat recorded 12 mentions for Tenet Healthcare and 2 mentions for Alcon. Tenet Healthcare's average media sentiment score of 1.31 beat Alcon's score of 1.24 indicating that Tenet Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tenet Healthcare	11 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alcon	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tenet Healthcare has higher revenue and earnings than Alcon. Tenet Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenet Healthcare	$21.31B	0.66	$1.41B	$19.23	8.43
Alcon	$10.40B	3.18	$980M	$1.66	40.25

95.4% of Tenet Healthcare shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 1.0% of Tenet Healthcare shares are held by insiders. Comparatively, 1.5% of Alcon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Tenet Healthcare beats Alcon on 13 of the 17 factors compared between the two stocks.

How does Alcon compare to Encompass Health?

Alcon (NYSE:ALC) and Encompass Health (NYSE:EHC) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

In the previous week, Encompass Health had 5 more articles in the media than Alcon. MarketBeat recorded 7 mentions for Encompass Health and 2 mentions for Alcon. Encompass Health's average media sentiment score of 1.34 beat Alcon's score of 1.24 indicating that Encompass Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Encompass Health	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alcon has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market. Comparatively, Encompass Health has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Encompass Health has a net margin of 10.04% compared to Alcon's net margin of 7.70%. Encompass Health's return on equity of 18.28% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
Encompass Health	10.04%	18.28%	8.27%

53.9% of Alcon shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 1.5% of Alcon shares are held by insiders. Comparatively, 1.8% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Alcon currently has a consensus target price of $85.12, suggesting a potential upside of 27.42%. Encompass Health has a consensus target price of $143.86, suggesting a potential upside of 37.80%. Given Encompass Health's stronger consensus rating and higher probable upside, analysts clearly believe Encompass Health is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63
Encompass Health	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00

Alcon has higher revenue and earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.18	$980M	$1.66	40.25
Encompass Health	$5.94B	1.74	$566.20M	$5.99	17.43

Summary

Encompass Health beats Alcon on 10 of the 16 factors compared between the two stocks.

Get Alcon News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALC vs. The Competition

Export

Metric	Alcon	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$33.05B	$7.20B	$6.64B	$23.35B
Dividend Yield	N/A	1.20%	2.68%	4.08%
P/E Ratio	40.25	45.87	23.84	30.26
Price / Sales	3.18	85.64	577.54	13.22
Price / Cash	12.18	24.88	42.42	24.41
Price / Book	1.50	6.95	9.73	4.63
Net Income	$980M	$159.22M	$3.57B	$1.07B
7 Day Performance	0.84%	-2.59%	-1.26%	-1.66%
1 Month Performance	1.75%	2.24%	0.82%	-1.68%
1 Year Performance	-24.01%	-1.02%	24.09%	21.33%

Alcon Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALC Alcon	4.0643 of 5 stars	$66.81 +0.3%	$85.12 +27.4%	-23.2%	$33.05B	$10.40B	40.25	25,942	Analyst Downgrade
COO Cooper Companies	3.9514 of 5 stars	$62.55 flat	$90.79 +45.1%	-5.4%	$12.20B	$4.09B	30.97	15,000	Trending News Earnings Report Analyst Forecast Gap Up
DXCM DexCom	4.5024 of 5 stars	$72.10 flat	$82.21 +14.0%	-15.0%	$27.82B	$4.66B	30.81	11,000	Trending News Analyst Forecast Insider Trade
HCA HCA Healthcare	4.7844 of 5 stars	$394.40 +0.1%	$515.77 +30.8%	-2.4%	$87.42B	$75.60B	13.56	320,000	Trending News Analyst Forecast
THC Tenet Healthcare	4.3907 of 5 stars	$174.00 +0.1%	$244.16 +40.3%	-5.5%	$14.97B	$21.31B	9.05	99,000	Positive News Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ALC) was last updated on 6/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alcon (ALC) Competitors

ALC vs. COO, DXCM, HCA, THC, and EHC

How does Alcon compare to Cooper Companies?

Summary

How does Alcon compare to DexCom?

Summary

How does Alcon compare to HCA Healthcare?

Summary

How does Alcon compare to Tenet Healthcare?

Summary

How does Alcon compare to Encompass Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALC vs. The Competition

Alcon Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alcon (ALC) Competitors

ALC vs. COO, DXCM, HCA, THC, and EHC

How does Alcon compare to Cooper Companies?

Do insiders and institutionals believe in COO or ALC?

Which has more risk and volatility, COO or ALC?

Do analysts prefer COO or ALC?

Does the media prefer COO or ALC?

Is COO or ALC more profitable?

Which has higher valuation and earnings, COO or ALC?

Summary

How does Alcon compare to DexCom?

Which has more risk and volatility, DXCM or ALC?

Does the media prefer DXCM or ALC?

Do analysts recommend DXCM or ALC?

Is DXCM or ALC more profitable?

Which has higher earnings and valuation, DXCM or ALC?

Do insiders & institutionals believe in DXCM or ALC?

Summary

How does Alcon compare to HCA Healthcare?

Do analysts recommend ALC or HCA?

Which has higher earnings and valuation, ALC or HCA?

Does the media refer more to ALC or HCA?

Which has more risk & volatility, ALC or HCA?

Do insiders and institutionals hold more shares of ALC or HCA?

Is ALC or HCA more profitable?

Summary

How does Alcon compare to Tenet Healthcare?

Is THC or ALC more profitable?

Do analysts recommend THC or ALC?

Which has more volatility & risk, THC or ALC?

Does the media favor THC or ALC?

Which has better valuation and earnings, THC or ALC?

Do insiders & institutionals hold more shares of THC or ALC?

Summary

How does Alcon compare to Encompass Health?

Does the media refer more to ALC or EHC?

Which has more risk and volatility, ALC or EHC?

Is ALC or EHC more profitable?

Do institutionals and insiders hold more shares of ALC or EHC?

Do analysts recommend ALC or EHC?

Which has stronger valuation & earnings, ALC or EHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALC vs. The Competition

Alcon Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools